Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer...

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• L-tryptophan (Trp) metabolism through the L-kynurenine (Kyn) pathway is implicated in cancer immune escape.
• Indoleamine 2,3-dioxygenase-1 (IDO1) is a key enzyme in this pathway, producing immunomodulatory catabolites like Kyn, 3HK, and 3HAA.

Purpose of the Study:

• To investigate the association between Kyn pathway enzyme expression and prognostic factors in bladder cancer (BC).
• To evaluate the impact of immune stimuli and IDO1 inhibition on BC cell lines.

Main Methods:

• Analysis of GEO DataSets from 165 BC patients, correlating enzyme expression (IDO1, AFMID, KAT, KYNU, KMO, HAAO, ACMSD) with staging, grade, progression, and recurrence.
• Evaluation of predictive genes in RT4 and T24 BC cells treated with IFN-gamma and an IDO1 inhibitor (INCB024360).
• Quantification of Trp catabolites in cell culture supernatants.

Main Results:

• Significant variations in enzyme expression were observed, with IDO1 and KMO correlating with advanced stages and KAT and KYNU with earlier stages/lower grades.
• T24 cells (high-grade) showed greater responsiveness to IFN-gamma than RT4 cells (low-grade), with altered enzyme expression patterns reversed by INCB024360.
• High Trp consumption led to increased Kyn and 3HAA, but not 3HK.

Conclusions:

• Kyn pathway enzyme expression patterns correlate with BC disease progression and may reflect immune activity within the tumor microenvironment.
• Bladder cancer cells exhibit differential sensitivity to immune stimuli, potentially influencing distinct immune escape strategies.